Ron Bentsur

Affiliations

  • Director at Beyond Air Inc. (XAIR), 2024-03-22
  • Chairman & Ceo at Nuvectis Pharma Inc. (NVCT), 2024-03-19
  • Director at Stemline Therapeutics Inc (STML), 2020-06-10
  • Chief Executive Officer at Urogen Pharma Ltd. (URGN), 2019-01-10
  • Chief Executive Officer at Keryx Biopharmaceuticals Inc (KERX), 2015-04-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NVCT $10.29 5,000 Large Shareholder, Officer, Director 3,242,484 2024-03-18 Filing
NVCT $11.08 640 Large Shareholder, Officer, Director 3,237,484 2023-10-10 Filing
NVCT $11.19 830 Large Shareholder, Officer, Director 3,236,844 2023-10-09 Filing
NVCT $11.27 250 Large Shareholder, Officer, Director 3,236,014 2023-10-06 Filing
NVCT $11.09 1,400 Large Shareholder, Officer, Director 3,235,764 2023-10-05 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XAIR $6.53 40,000 Director 142,436 2022-06-30 Filing
XAIR $13.99 6,464 Director 182,436 2021-11-24 Filing
XAIR $13.44 31,000 Director 188,900 2021-11-24 Filing
XAIR $6.36 23,419 Director 182,436 2021-02-12 Filing
XAIR $6.28 1,500 Director 182,436 2021-02-11 Filing